Getagraph.com logo
NASDAQ Composite: ( -0.01%) 16 735
S&P 500
(0.80%) 5 277.51 points
Dow Jones
(1.51%) 38 686 points
Nasdaq
(-0.01%) 16 735 points
Oil
(-0.94%) $77.18
Gas
(0.35%) $2.58
Gold
(-0.79%) $2 347.70
Silver
(-3.10%) $30.56
Platinum
(0.63%) $1 044.50
USD/EUR
(-0.17%) $0.921
USD/NOK
(-0.49%) $10.49
USD/GBP
(-0.05%) $0.785
USD/RUB
(0.15%) $90.40

Realtime updates for Edgewise Therapeutics, [EWTX]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology
BUY
33.33%
return -4.55%
SELL
66.67%
return 0.50%
Last Updated31 May 2024 @ 16:00
25% discount on Stockinvest.us - Use code: Podcast

-2.11% $ 17.13

BUY 155202 min ago

@ $18.60

Issued: 14 Feb 2024 @ 12:04

Return: -7.90%

Previous signal: Feb 13 - 14:56

Previous signal: Sell

Return: 2.65 %

Live Chart Being Loaded With Signals

Commentary (31 May 2024 @ 16:00):
Profile picture for Edgewise Therapeutics, Inc.

Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has completed Phase 1 clinical trial...

Stats
Today's Volume 860 706
Average Volume 704 601
Market Cap 1.60B
EPS $0 ( 2024-05-09 )
Next earnings date ( $-0.390 ) 2024-06-07
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -11.12
ATR14 $0.0330 (0.19%)
Insider Trading
Date Person Action Amount type
2024-05-06 Morris Arlene Buy 34 311 Stock Options (Right to buy)
2024-05-06 Morris Arlene Buy 0
2024-05-01 Moore John R Sell 5 208 Restricted Stock Units
2024-05-01 Moore John R Buy 5 208 Common Stock
2024-05-02 Moore John R Sell 1 956 Common Stock
INSIDER POWER
70.98
Last 96 transactions
Buy: 6 453 320 | Sell: 592 683

Volume Correlation

Long: -0.24 (neutral)
Short: -0.04 (neutral)
Signal:(46.226) Neutral

Edgewise Therapeutics, Correlation

10 Most Positive Correlations
FFNW0.883
AGNCO0.828
TIL0.823
CLST0.815
FSEA0.81
10 Most Negative Correlations
RNAZ-0.879
CNSP-0.878
ALTO-0.866
AXDX-0.86
WINT-0.856
ALLK-0.855
IKNA-0.854
IDEX-0.853
PLL-0.851
UXIN-0.85

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Edgewise Therapeutics, Correlation - Currency/Commodity

The country flag 0.79
( moderate )
The country flag 0.54
( weak )
The country flag 0.00
( neutral )
The country flag 0.69
( moderate )
The country flag 0.04
( neutral )
The country flag 0.63
( weak )

Edgewise Therapeutics, Financials

Annual 2023
Revenue: $0
Gross Profit: $-1.73M (0.00 %)
EPS: $-1.570
FY 2023
Revenue: $0
Gross Profit: $-1.73M (0.00 %)
EPS: $-1.570
FY 2022
Revenue: $0
Gross Profit: $-538 000 (0.00 %)
EPS: $-0.290
FY 2021
Revenue: $0.00
Gross Profit: $0.00 (0.00 %)
EPS: $-1.140

Financial Reports:

No articles found.

Edgewise Therapeutics, Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Edgewise Therapeutics,

Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has completed Phase 1 clinical trial. It develops a pipeline of precision medicine product candidates that target key muscle proteins and modulators to address genetically defined muscle disorders. Edgewise Therapeutics, Inc. was incorporated in 2017 and is headquartered in Boulder, Colorado.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators

Total Execution Time: 1.3707988262177 seconds
Number of API calls: 2
Number of DB calls: 8